Indian Journal of Urology (Jan 2021)

Checkmate 274 trial: Is Nivolumab the new standard in adjuvant setting for high-risk muscle invasive urothelial carcinoma?

  • Naveen Kumar

DOI
https://doi.org/10.4103/iju.iju_288_21
Journal volume & issue
Vol. 37, no. 4
pp. 369 – 371

Abstract

Read online

No abstracts available.